M.Sc

The Dr. Reddy's Institute of Life Sciences was conceived in the context of globalization, to foster research competence in India and to bridge the divide between academic research and the pharmaceutical & biotechnology industries.  The institute was incorporated as a non-profit entity under Section 25 of the Indian companies act, facilitating operational autonomy. Construction of the DRILS building comprising 44 labs and an administrative block and spanning ~130,000 sq.ft. in area, began in 2004 and was completed in January 2007.

Applications are invited for the Junior Research Fellowship (temporary position) in Organic / Medicinal Chemistry to work on a DST funded research project.

HETERO, research based approved USFDA, TGA, EU, PMDA, KFDA and WHO global pharmaceutical company established in 1993, focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages.

Shilpa Medicare Ltd. SEZ-Formulation Unit, we are among the fastest growing oncology formulation pharmaceutical company, looking for dynamic young energetic, creative and talented mate candidates for formulation unit at Jadcherla near Hyderabad

Panjab University has been Accredited with a CGPA of 3.35 on a four point scale at A Grade valid for a period of 5 years from 25/06/2015. 1st among Universities of India and 38th in Asia, Times Higher Education Asian University rankings 2015. Ranked number one University in India and in the bracket 276-300 internationally in the Times Higher Education World University Rankings, 2014-2015 powered by Thomson Reuters.

Aurigene is a specialized biotech company, focused on oncology and inflammatory diseases. Aurigene has deep target and therapeutic area expertise, gained from the experience of multiple programs reaching global clinical development from its efforts. Aurigene has pioneered a unique, collaborative business model to work with pharma and biotech partners, in a win-win partnership that combines Aurigene’s deep expertise in oncology and inflammation, with our collaboration partners’ needs for expertise, scalability and high-quality, quick and cost-effective prosecution of targets.

Post : Group Leader/Sr. Group Leader/Assoc. Dir. - Clinical Operations

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Global Technical Project Manager

Cactus Communications—a company dedicated to the pursuit of good English. We provide editing, educational, transcription, and training services to individual and institutional clients worldwide. All our businesses are linked together by one common factor—great written English. Since our establishment in April 2002, we have carved a niche for ourselves as a company providing language solutions of the highest quality.

Post:  Freelance Pharma/Regulatory Editor

We’re a global biotechnology company dedicated to improving the human condition. Our industry-leading brands are found in nearly every life sciences lab in the world, including innovative instrument systems under the Applied Biosystems and Ion Torrent names. We’re also responsible for a broad range of reagents with our Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. With approximately 3,900 patents and exclusive licenses, we’re home to one of the largest intellectual property estates in the life sciences industry

Post : Product Specialist

Piramal Enterprises Ltd. provides a world class integrated drug discovery services platform from our state-of-the-art research Centre in India. PDS's delivery model has a proven track record of providing a step change in the effectiveness of drug discovery for a range of global pharmaceuticals and biotechnology companies operating at the forefront of drug discovery. PDS understands that early and intensive evaluation of the molecules based on thorough communications and rapid decision-making will lead to a high throughput of successful drug-like compounds.

Post : Executive - Q.A